Cargando…
Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor‐β‐induced expression in urothelial carcinoma
Transforming growth factor‐β‐induced (TGFΒI) is considered to be a vital gene in several carcinomas. In this study we determined the effect of TGFBI on the proliferative and metastatic potential of human urothelial carcinoma (UC) cells as well as its mRNA and protein expression, which were detected...
Autores principales: | Shang, Donghao, Song, Bo, Liu, Yuting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891197/ https://www.ncbi.nlm.nih.gov/pubmed/28940965 http://dx.doi.org/10.1111/cas.13403 |
Ejemplares similares
-
Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting LEF1/β-catenin signaling
por: Shang, Donghao, et al.
Publicado: (2020) -
Exosome-Transmitted miR-128 Targets CCL18 to Inhibit the Proliferation and Metastasis of Urothelial Carcinoma
por: Shang, Donghao, et al.
Publicado: (2022) -
Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma
por: Shang, Donghao, et al.
Publicado: (2021) -
Epirubicin-gold nanoparticles suppress hepatocellular carcinoma xenograft growth in nude mice
por: Meng, William C. S., et al.
Publicado: (2015) -
Randomised trial of epirubicin alone versus 5-fluorouracil, epirubicin and mitomycin C in locally advanced and metastatic carcinoma of the pancreas.
por: Topham, C., et al.
Publicado: (1991)